Loading clinical trials...
Loading clinical trials...
Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NCT05515757 · Amphetamine-Related Disorders
NCT01386177 · Mood Disorder, Substance-Related Disorders, and more
NCT00033072 · Amphetamine-Related Disorders
NCT02797990 · Substance-Related Disorders, Alcohol-Related Disorders, and more
NCT02294266 · Amphetamine-Related Disorders, Alcohol-Related Disorders
Friends Research Institute
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions